Avitide, Inc.

Avitide, Inc.

Avitide, Inc.

Avitide develops customized biopharmaceutical affinity purification products with an industryleading discovery and development service timeline.
Founded
2012
Follow us
Alexa global traffic share
Latest funding
Undisclosed amount
Venture capital (Series E) - 2017
Borealis Ventures Polaris Partners Mithril Capital Management +3
Undisclosed amount
Venture capital (Series D) - 2016
Mithril Capital Management
Team Size
10+
Employees
MedCity News

Repligen sees $150M Avitide acquisition as key to reaching gene therapy goals

Venture capital (Series E)
businesswire , PE HUB

Avitide, Inc., Raises Series E Financing from Sands Capital Ventures with Broad Participation from Early Investors

Venture capital (Series D)
businesswire

Avitide, Inc., Secures Series D Financing from Mithril to Expand Affinity Resin Discovery Platform and Resin Manufacturi...